Switchboard Acquires MSK Referral Tech, Raises $5M
Switchboard Health Acquires Livara, Lands $5M to Embed MSK Value-Based Care
Switchboard Health has acquired Livara Health and closed a $5M funding round to integrate Livara's musculoskeletal care program directly into its referral management and care navigation platform. The move signals a shift toward embedding clinical outcome models into automation workflows—a tactic that could reshape how health systems manage high-cost specialty referrals and improve claim adjudication on the backend.The Deal
Switchboard acquired Livara Health, which operates a value-based MSK program focused on conservative care and outcomes tracking. Terms of the acquisition were not disclosed. The $5M funding round will accelerate development of integrated referral orchestration and care navigation features, with Livara's clinical protocols embedded into Switchboard's referral management layer. No close date was specified in available reporting.
What It Means for RCM
- Upstream claim management. By embedding outcome-driven MSK protocols into the referral workflow, Switchboard reduces downstream claim denials tied to medical necessity disputes. RCM teams see faster authorization turnarounds and fewer rework cycles on orthopedic and spine referrals.
- Referral network standardization. Health systems using Switchboard now have a built-in preferred pathway for MSK cases, which can improve payor contract compliance and reduce out-of-network leakage on high-cost specialties.
- Data for contracting leverage. The integration creates a standardized outcome dataset on MSK cases—useful ammunition for health systems negotiating value-based arrangements with payers or defending medical necessity in appeal cycles.
Market Context
Funding in healthcare automation and referral management continues to accelerate as health systems prioritize operational efficiency and payers demand outcome evidence before authorizing elective procedures. Acquisitions like this one—where clinical protocols merge with RCM automation—reflect a broader industry shift away from standalone point solutions toward integrated care pathways. MSK is a natural target: high-cost, high-volume, and often defensible through conservative care protocols. Switchboard's move to own clinical IP rather than simply integrate third-party data positions the company competitively in a crowded referral management space dominated by vendors chasing payor relationships.
Free Daily RCM Intelligence
Denial trends, payer policy moves, vendor intel — delivered every morning. Free.